Discovery provides new drug targets for malaria cure

Jan 11, 2010

Researchers are a step closer to developing new antimalarial drugs after discovering the normal function of a set of proteins related to the malaria parasite protein, which causes resistance to the front-line drug chloroquine. The findings also provide a novel tool for studying the malarial chloroquine-resistance factor.

The study examined transporter proteins which are known to move compounds around the cell. The genes for these proteins are present in plants as well as the Plasmodium falciparum (known as clt and PfCRT respectively), so researchers used the model plant Arabidopsis to reveal that these proteins normally transport glutathione, an antioxidant which protects the cell from stresses.

In the parasite (a single cell organism), this type of transporter protein has mutated so that it no longer functions normally, enabling it to remove the drug from its cell and survive.

Plasmodium falciparum is the most dangerous of the malaria infections being transmitted by the female Anopheles mosquito. It has the highest rates of complications and mortality and is responsible for up to one million deaths per year, mostly children in Africa under the age of five. The evolution of drug-resistant Plasmodium strains, especially those resistant to chloroquine, has had major impacts on global public health. The economic toll is also huge with destroying more than 1% of African GPD.

The work was led by Dr Spencer Maughan who began researching these genes in Prof. Chris Cobbett's lab in the Department of Genetics at the University of Melbourne and involved an international team from the Universities of Melbourne, Cambridge (UK), Heidelberg (Germany), Liverpool (UK) and Rothamsted Research (UK). It will be published in the prestigious international journal PNAS this week.

"Our findings set in motion the chance of reclaiming the efficacy of chloroquine which could turn the tide on the war against malaria and ultimately may help save millions of lives," said Dr Maughan.

"The transporter is normally essential to the survival of the malaria parasite and when mutated, provides the extra advantage of removing the drug chloroquine from its cell.

"We hope that understanding the normal role of the transporter in plants will be a key step in malaria research. Unlike in the plant, if the gene for the transporter is inactivated in malaria, the parasite dies, preventing more study into its role. The plant could therefore provide a useful tool in malaria research."

"These results describe the first missing link in understanding this class of proteins and could provide a two-pronged treatment approach- preventing malaria removing chloroquine from its cell and enabling the design of new drugs based on the shape of glutathione."

Explore further: Research milestone in CCHF virus could help identify new treatments

Related Stories

Progress in understanding the malarial parasite

Sep 14, 2007

About 2 million people die of malaria every year, of which more than a million are children in sub-Saharan Africa. Malaria is caused by a protozoan parasite belonging to the genus Plasmodium, and Plasmodium falciparum is ...

Recommended for you

A new way to prevent the spread of devastating diseases

11 hours ago

For decades, researchers have tried to develop broadly effective vaccines to prevent the spread of illnesses such as HIV, malaria, and tuberculosis. While limited progress has been made along these lines, ...

New molecule allows for increase in stem cell transplants

12 hours ago

Investigators from the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal have just published, in the prestigious magazine Science, the announcement of the discovery of a new molecule, the fi ...

Team explores STXBP5 gene and its role in blood clotting

14 hours ago

Two independent groups of researchers led by Sidney (Wally) Whiteheart, PhD, of the University of Kentucky, and Charles Lowenstein, MD, of the University of Rochester, have published important studies exploring the role that ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

fixer
not rated yet Jan 12, 2010
Hang on, Hydrochloroquine replaced chloroquine years ago.
A.Annua replaced Hydrochloroquine which was modified into A.Annua Anamed as a superior strain and is still the benchmark in Africa.
In Asia Artemisinin distilled from A.Annua became the gold standard until screwed up by unscrupulous chinese operators out for a fast buck which led to Artemisinin Combination Therapy (ACT) which is now the W.H.O.s drug of choice for Plasmodium falciparum malaria.
Last time I looked, they did'nt have Plasmodium falciparum in Melbourne, maybe they were thinking of cockroaches and got the photo wrong or something.